OrphanDrug
OrphanDrug
Pharma Knowledge Base

hereditary spastic paraplegia 64

ORPHA: 401810

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

gene (10q24.1), encoding ectonucleoside triphosphate diphosphohydrolase 1.

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with hereditary spastic paraplegia 64, sourced from HPO and Orphanet clinical annotations.

MicrocephalyAggressive behaviorDelayed pubertySpasticityDysarthriaGait disturbanceBorderline intellectual disabilityAreflexiaAbnormal cerebral white matter morphology

Classification & Codes

Orphanet Code

ORPHA:401810
hereditary spastic paraplegia 64
OrphanetORPHA:401810
Treatments0 drug(s)
Symptoms on record9 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO
hereditary spastic paraplegia 64 | OrphanDrug